Antithrombin gamma

DB16094InvestigationalProtein Based Therapies

Antithrombin gamma is under investigation in clinical trial NCT04182373 (KW-3357 Study in Patients With Early Onset Severe Preeclampsia).

Also known as
Acoalan · Afucosylated antithrombin · Antithrombin (human variant kw-3357) · Antithrombin gamma (genetical recombination) · Human antithrombin-iii (atiii, serpin c1) expressed in fucosyl transferase-negative chinese hamster ovary (cho) cells (glycoform gamma)

Resolves to

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Antithrombin gamma, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account